141 related articles for article (PubMed ID: 38085184)
21. Pilot study of fractional CO
Quick AM; Dockter T; Le-Rademacher J; Salani R; Hudson C; Hundley A; Terstriep S; Streicher L; Faubion S; Loprinzi CL; Coleman JS; Wang KC; Lustberg M
Maturitas; 2021 Feb; 144():37-44. PubMed ID: 33358206
[TBL] [Abstract][Full Text] [Related]
22. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
[TBL] [Abstract][Full Text] [Related]
23. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
24. Microablative Fractional CO
Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
[TBL] [Abstract][Full Text] [Related]
25. Fractional CO
Murina F; Karram M; Salvatore S; Felice R
J Sex Med; 2016 Dec; 13(12):1915-1917. PubMed ID: 27864031
[TBL] [Abstract][Full Text] [Related]
26. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
Sokol ER; Karram MM
Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
[TBL] [Abstract][Full Text] [Related]
27. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of fractional CO
Tovar-Huamani J; Mercado-Olivares F; Grandez-Urbina JA; Pichardo-Rodriguez R; Tovar-Huamani M; García-Perdomo H
Lasers Surg Med; 2019 Aug; 51(6):509-515. PubMed ID: 30779363
[TBL] [Abstract][Full Text] [Related]
29. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial.
Politano CA; Costa-Paiva L; Aguiar LB; Machado HC; Baccaro LF
Menopause; 2019 Aug; 26(8):833-840. PubMed ID: 31246661
[TBL] [Abstract][Full Text] [Related]
30. Microablative fractional radiofrequency for the genitourinary syndrome of menopause: protocol of randomised controlled trial.
Sarmento ACA; Fernandes FS; Costa APF; Medeiros KS; Crispim JC; Gonçalves AK
BMJ Open; 2021 Jul; 11(7):e046372. PubMed ID: 34226218
[TBL] [Abstract][Full Text] [Related]
31. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
32. Fractional Co
Alexiades MR
Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
[TBL] [Abstract][Full Text] [Related]
33. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
34. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis.
Jang YC; Leung CY; Huang HL
JAMA Netw Open; 2022 Sep; 5(9):e2232563. PubMed ID: 36129710
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser.
D'Oria O; Giannini A; Prata G; Scudo M; Logoteta A; Mondo A; Perniola G; Palaia I; Cascialli G; Monti M; Muzii L; Benedetti Panici P; DI Donato V
Minerva Obstet Gynecol; 2021 Apr; 73(2):127-134. PubMed ID: 32720802
[TBL] [Abstract][Full Text] [Related]
37. Microablative fractional CO
Pitsouni E; Grigoriadis T; Falagas M; Tsiveleka A; Salvatore S; Athanasiou S
Lasers Med Sci; 2017 Nov; 32(8):1865-1872. PubMed ID: 28770400
[TBL] [Abstract][Full Text] [Related]
38. Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial.
Slongo H; Lunardi ALB; Riccetto CLZ; Machado HC; Juliato CRT
Int Urogynecol J; 2022 Jan; 33(1):53-64. PubMed ID: 33837797
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Vaginal Microablative Fractional CO
Takacs P; Sipos AG; Kozma B; Cunningham TD; Larson K; Lampé R; Poka R
Lasers Surg Med; 2020 Oct; 52(8):708-712. PubMed ID: 31919864
[TBL] [Abstract][Full Text] [Related]
40. Use of a vaginal CO
Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
